Marion Jones, vice president of workforce development in the solar energy industry and ambassador for The Sumaira Foundation, ...

A Buffalo teenager is smiling through an extremely rare medical condition that’s taken away her control of her body twice now ...

Avery Russek, 17, is fighting an extremely rare autoimmune disease called opsoclonus myoclonus, a condition she was first ...

A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare autoimmune disease of the peripheral nervous system. This treatment modifies ...

BANGOR -- Autumn Scott, a 17-year-old from Dixmont, is facing a tough battle with a rare autoimmune disease called Degos.

And patients are the ones who lose out. Letter" The 'big beautiful bill' is not compassionate conservatism but cruelty codified I know what it means to wait I live with two rare autoimmune diseases. I ...

Risk of death among people with rare autoimmune diseases compared to the general population in England during the 2020 COVID-19 pandemic. Rheumatology, 2020; DOI: 10.1093/rheumatology/keaa855; ...

Another rare autoimmune disease, uveitis, affects ~ 38 individuals per 100,000. Similar to other autoimmune disorders, this inflammatory disease of the eye often presents in younger patients (< 40 ...

I went to the Cleveland Clinic during this episode and finally learned the name of my illness: Adult-onset Stills disease, a very rare autoinflammatory disease that will always lurk inside my body ...

CIDP is an autoimmune disease in which the immune system's B-cells attack the peripheral nervous system. In the current study, the CAR CD19 T-cell therapy was used to combat these rogue B-cells.

A TEENAGE GIRL IN FRUITLAND PARK CONTRACTED A RARE AUTOIMMUNE DISEASE THAT CAN CAUSE SEIZURES AND HALLUCINATIONS. SUMMER: BUT BECAUSE IT’S SO RARE, IT CAN BE DIFFICULT TO DIAGNOSE. WESH 2’S ...

Researchers find that a small percentage of patients with unexplained epilepsy marked by partial seizures may test positive for autoantibodies and respond to immune-modulating therapy.